Transportation & Logistics

UK Healthcare Cold Chain: Market Demand, Specialist Infrastructure and Distribution Economics

From Pharma to vaccines to biologics, how temperature-sensitive products shape investment, competition and commercial risks across healthcare markets

In this briefing
  1. Introduction
  2. What counts as healthcare cold chain logistics?
  3. Demand: biologics, vaccines and evolving service requirements
  4. Estimating UK market size
  5. The infrastructure behind temperature assurance
  6. Competing across multiple segments
  7. How cold-chain logistics providers earn revenue
  8. Temperature excursions, liability and the value of evidence
  9. Environmental and investment considerations
  10. Conclusion
  11. About the Author
  12. Frequently Asked Questions
  13. References
  14. Disclaimer

Introduction

The commercial value of cold-chain logistics does not lie simply in refrigerated vehicles. It lies in the ability to maintain specified product conditions through storage, handling, transfers and delivery, with evidence sufficient to investigate exceptions. A missed delivery may be recoverable; an undocumented temperature excursion involving a costly medicine can trigger quarantine, investigation and potential loss of stock. Those differences influence infrastructure investment, supplier selection and contract economics.

The UK market brings together pharmaceutical manufacturers, wholesalers, specialist third-party logistics businesses, healthcare commissioners and providers. Vaccine programmes, biologic therapies and certain advanced medicines create demand for qualified storage and transportation. But the value of the medicines travelling through these networks is not the revenue earned by logistics operators. That distinction is essential in market sizing and in commercial due diligence.

This third briefing examines the cold chain as a specialist logistics market. It does not assess clinical homecare services, appliance dispensing or the economics of individual therapies, which belong to separate CPO Insights briefings. Detailed sourcing procedures and overarching logistics contract governance follow in Part 4.

What counts as healthcare cold chain logistics?

Cold chain covers the facilities, processes and evidence needed to preserve products within their required temperature conditions from release into distribution to receipt by the next responsible party. It can encompass manufacturer dispatch, wholesale storage, cross-docking, regional holding, onward movement and delivery to hospitals, pharmacies, general practices and other healthcare locations. Some providers perform the entire service; others specialise in one link.

It is not a single temperature band. Refrigerated products commonly require 2°C to…

Continue with membership

The rest of this briefing is available to active CPO Insights members.

This briefing reflects the author's analysis and understanding of the market, based on professional experience and information available at the time of publication. It is provided for information and discussion and is not legal, financial, investment or other professional advice. Full disclaimer.

About the author

Ajay Channana is a senior procurement and commercial practitioner with more than two decades of senior commercial leadership experience across public and private sector organisations. He established Ipso Facto Consulting Limited in 2016.

Need deeper intelligence?

Bespoke commercial intelligence on markets, spend categories and sectors, from public or private perspectives.

Receive new CPO Insights briefings

Receive the commercial developments, deals and procurement signals worth watching. Enter your email and we will send a 6-digit code to confirm it is yours.

Confirm your email to read briefings in full. No password or account needed. You’ll also receive a digest of new releases. Unsubscribe at any time; we never sell or share your information. Privacy notice